Drug Profile


Alternative Names: A-65006; AG-1749; Agopton; Bamalite; Estomil; Ilsatec; Lampion; Lansap; Lansone; Lansox; Lanzo; Lanzor; Limpidex; Ogast; Ogastro; Opiren; Prevacid; Prevacid 24HR; Prezal; Pro-Ulco; Takepron; Takepron Capsules 15; Takepron OD Tablets 15; TakepronIV; Zoton

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Takeda
  • Class Antiulcers; Benzimidazoles; Gastric antisecretories; Pyridines; Small molecules; Sulfoxides
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
  • No development reported Gastritis
  • Discontinued Bleeding ulcer

Most Recent Events

  • 08 Mar 2016 Biomarkers information updated
  • 21 Feb 2013 Registered for Gastritis (in combination with amoxicillin and clarithromycin or metronidazole as triple therapy for Helicobacter pylori gastritis) in Japan (PO)
  • 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top